5AM Ventures VI, L.P.
Insider CIK 1753037 · ELVN 10% owner · CAMP 10% owner · VOR 10% owner · ARTV 10% owner · FVAM 10% owner · CINC 10% owner · LTGO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | $0 | 4,975,543 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | $0 | 2,350,419 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | — | 2,350,419 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | — | 4,975,543 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy deriv | 2026-08-03 | 2026-08-05 | 3,179,558 | $1.53 | $4.86M | 3,179,558 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy deriv | 2026-08-03 | 2026-08-05 | 3,179,558 | $1.53 | $4.86M | 3,179,558 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-15 | 2,941,176 | $1.53 | $4.50M | 2,941,176 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 4,244,770 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 3,395,816 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 15,002,166 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-15 | 909,090 | $11.00 | $10.00M | 2,625,145 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 302,770 | — | $0 | 302,770 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 1,716,055 | — | $0 | 1,716,055 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 843,592 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 214,692 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 833,333 | $12.00 | $10.00M | 1,182,054 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 1,058,284 | — | $0 | 1,058,284 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 112,966 | $10.20 | $1.15M | 1,171,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 348,721 | $10.20 | $3.56M | 348,721 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-14 | 2024-02-16 | 688,358 | $14.90 | $10.26M | 3,200,634 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-14 | 2024-02-16 | 136,642 | $14.90 | $2.04M | 635,341 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 82,813 | $15.00 | $1.24M | 771,983 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 417,187 | $15.00 | $6.26M | 3,888,992 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-26 | 2023-09-28 | 32,711 | $15.00 | $490.7K | 854,796 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-26 | 2023-09-28 | 164,789 | $15.00 | $2.47M | 4,306,179 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-08-24 | 2023-08-28 | 367,124 | $16.00 | $5.87M | 4,470,968 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-08-24 | 2023-08-28 | 72,876 | $16.00 | $1.17M | 887,507 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 496,323 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 3,953,990 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 487,333 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 112,667 | $30.00 | $3.38M | 3,953,990 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 487,333 | $30.00 | $14.62M | 487,333 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 625,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 2,525,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 9,999,999 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 312,500 | $16.00 | $5.00M | 496,323 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 157,500 | $16.00 | $2.52M | 3,841,323 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 183,823 | — | $0 | 183,823 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 3,683,823 | — | $0 | 3,683,823 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2021-11-16 | 2021-11-18 | 238,870 | $15.30 | $3.65M | 4,595,089 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2021-11-16 | 2021-11-18 | 91,836 | $15.30 | $1.41M | 1,766,634 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 19,230,768 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 19,230,768 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 45,000,000 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 3,308,822 | — | $0 | 3,308,822 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,414,026 | — | $0 | 4,722,848 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,414,026 | — | $0 | 1,414,026 | SEC↗ |
| VOR Vor Biopharma Inc. | P Buy | 2021-02-09 | 2021-02-09 | 444,444 | $18.00 | $8.00M | 1,858,470 | SEC↗ |
| VOR Vor Biopharma Inc. | P Buy | 2021-02-09 | 2021-02-09 | 111,111 | $18.00 | $2.00M | 4,833,959 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-11-30 | 2020-12-01 | 235,932 | — | $0 | 1,944,068 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-11-17 | 2020-11-18 | 30,000 | — | $0 | 2,180,000 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other | 2020-11-12 | 2020-11-12 | 5,126 | $10.00 | $51.3K | 365,126 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-10-16 | 2020-10-20 | 90,000 | — | $0 | 2,210,000 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other | 2020-10-16 | 2020-10-20 | 360,000 | $10.00 | $3.60M | 360,000 | SEC↗ |